PMC:7105881 / 33209-33456 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T178","span":{"begin":154,"end":158},"obj":"Disease"}],"attributes":[{"id":"A178","pred":"mondo_id","subj":"T178","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"tains multiple conformation-dependent epitopes capable of eliciting high-titer neutralizing antibodies; thus, it is a major target for the development of SARS vaccines (He et al., 2004, 2005a; Jiang et al., 2012; Zhu et al., 2013). Subunit vaccine"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T440","span":{"begin":116,"end":117},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"tains multiple conformation-dependent epitopes capable of eliciting high-titer neutralizing antibodies; thus, it is a major target for the development of SARS vaccines (He et al., 2004, 2005a; Jiang et al., 2012; Zhu et al., 2013). Subunit vaccine"}

    2_test

    {"project":"2_test","denotations":[{"id":"32265848-15474494-36511136","span":{"begin":180,"end":184},"obj":"15474494"},{"id":"32265848-23252385-36511138","span":{"begin":207,"end":211},"obj":"23252385"},{"id":"32265848-23977435-36511139","span":{"begin":225,"end":229},"obj":"23977435"}],"text":"tains multiple conformation-dependent epitopes capable of eliciting high-titer neutralizing antibodies; thus, it is a major target for the development of SARS vaccines (He et al., 2004, 2005a; Jiang et al., 2012; Zhu et al., 2013). Subunit vaccine"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T557","span":{"begin":38,"end":46},"obj":"BV_9"},{"id":"T558","span":{"begin":92,"end":102},"obj":"GO:0042571"},{"id":"T559","span":{"begin":154,"end":158},"obj":"SP_10"},{"id":"T62823","span":{"begin":38,"end":46},"obj":"BV_9"},{"id":"T18461","span":{"begin":92,"end":102},"obj":"GO:0042571"},{"id":"T90326","span":{"begin":154,"end":158},"obj":"SP_10"}],"text":"tains multiple conformation-dependent epitopes capable of eliciting high-titer neutralizing antibodies; thus, it is a major target for the development of SARS vaccines (He et al., 2004, 2005a; Jiang et al., 2012; Zhu et al., 2013). Subunit vaccine"}